Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501YMA30 Strain of SARS-CoV-2Karen V. Kibler, Bertram L. Jacobs, Mateusz Szczerba et al.|Vaccines|2022Cited by 14
Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infectionLiqiang Zhang, Alexandra Lucas, Karen V. Kibler et al.|EMBO Molecular Medicine|2023Cited by 12
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y <sub>MA30</sub> strain of SARS-CoV-2Karen V. Kibler, Bertram L. Jacobs, Douglas F. Lake et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 8
Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus ReplicationMasmudur M. Rahman, Brenda G. Hogue, Bereket Estifanos et al.|Viruses|2025Cited by 4
Effect of exportin 1/XPO1 nuclear export pathway inhibition on coronavirus replicationMasmudur M. Rahman, Brenda G. Hogue, Bereket Estifanos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3